# Tomás Berl

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/tomas-berl/

## Facts

| Field | Value |
| --- | --- |
| Citations | 20,695 |
| Field | Electrolyte and hormonal disorders |
| h-index | 62 |
| i10-index | 151 |
| Last Known Institution | University of Colorado Anschutz Medical Campus |
| OpenAlex ID | https://openalex.org/A5020007756 |
| Works | 208 |

## Researcher papers

- [Renoprotective Effect of the Angiotensin-Receptor Antagonist Irbesartan in Patients with Nephropathy Due to Type 2 Diabetes](https://scholariq.org/papers/renoprotective-effect-of-the-angiotensin-receptor-antagonist-irbesartan-in/)
- [Tolvaptan, a Selective Oral Vasopressin V <sub>2</sub> -Receptor Antagonist, for Hyponatremia](https://scholariq.org/papers/tolvaptan-a-selective-oral-vasopressin-v-sub-2-sub-receptor-antagonist-for/)
- [Cardio-renal syndromes: report from the consensus conference of the Acute Dialysis Quality Initiative](https://scholariq.org/papers/cardio-renal-syndromes-report-from-the-consensus-conference-of-the-acute/)
- [Radioimmunoassay of Plasma Arginine Vasopressin in Hyponatremic Patients with Congestive Heart Failure](https://scholariq.org/papers/radioimmunoassay-of-plasma-arginine-vasopressin-in-hyponatremic-patients-with/)
- [Oral Tolvaptan Is Safe and Effective in Chronic Hyponatremia](https://scholariq.org/papers/oral-tolvaptan-is-safe-and-effective-in-chronic-hyponatremia/)
- [A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of AST-120 (Kremezin) in Patients With Moderate to Severe CKD](https://scholariq.org/papers/a-multicenter-randomized-double-blind-placebo-controlled-dose-ranging-study-of/)
- [Efficacy and safety of oral tolvaptan therapy in patients with the syndrome of inappropriate antidiuretic hormone secretion](https://scholariq.org/papers/efficacy-and-safety-of-oral-tolvaptan-therapy-in-patients-with-the-syndrome-of/)

## Researcher topics

- [Electrolyte and hormonal disorders](https://scholariq.org/topics/electrolyte-and-hormonal-disorders/)
- [Ion Transport and Channel Regulation](https://scholariq.org/topics/ion-transport-and-channel-regulation/)
- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)
- [Neuroendocrine regulation and behavior](https://scholariq.org/topics/neuroendocrine-regulation-and-behavior/)
- [Renal function and acid-base balance](https://scholariq.org/topics/renal-function-and-acid-base-balance/)

## Researcher university

- [University of Colorado Anschutz Medical Campus](https://scholariq.org/institutions/university-of-colorado-anschutz-medical-campus/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.